Wyngaarden To Step Down As NIH Director

WASHINGTON—The resignation of James Wyngaarden last month after more than seven years as director of the National Institutes of Health may have caught scientists by surprise. But it was a long time coming for the 64-year-old Wyngaarden. In fact, his last day on the job, July 31, will be nine months past the date when the soft-spoken former Duke University medical schcol administrator had hoped to leave the post. It’s clear that Wyngaarden has had his fill of the political battles

Written byJeffrey Mervis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON—The resignation of James Wyngaarden last month after more than seven years as director of the National Institutes of Health may have caught scientists by surprise. But it was a long time coming for the 64-year-old Wyngaarden. In fact, his last day on the job, July 31, will be nine months past the date when the soft-spoken former Duke University medical schcol administrator had hoped to leave the post.

It’s clear that Wyngaarden has had his fill of the political battles that go with his position. Speaking candidly about the Reagan years, he admits that “we’ve had no consistent science policy” for that entire period. He describes the annual budget process as a situation where “the administration tries to get by with as little as it can, and then Congress repairs the damage to the greatest extent possible.”

That constant struggle for funds can be exhausting, Wyngaarden admits. “Last year ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery